Refametinib (RDEA-119, BAY 86-9766)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Refametinib, also known as RDEA119, BAY 86-9766, is an orally bioavailable selective MEK inhibitor with potential antineoplastic activity. | ||
---|---|---|---|
Targets |
|
Catalog Num | A12866 |
---|---|
Formula | C19H20F3IN2O5S |
Molecular Weight | 572.34 |
CAS Number | 923032-38-6 |
SMILES | COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F |
Synonyms | RDEA119, RDEA 119, BAY 86-9766, BAY 869766, BAY869766 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2